LAUSR

In essence, the debate crystalized around the potential health benefits of early cancer detection versus the potential anxiety that would be generated at a particularly vulnerable time during pregnancy. Dr. Plon drew upon her clinical experience in a cancer genomics clinic and emphasized the importance of not keeping “harmful secrets” from individuals. In contrast, Dr. Benn drew upon his experience as a clinical genetics laboratory director, focusing on his concerns regarding the release of a test that has not been designed or validated for cancer screening. After some audience questions, voting was repeated, and the majority of the audience once again voted in favor of disclosing incidental NIPT results that suggest maternal cancer.